Comparable Serum and Plasma 1,3-β-D-Glucan Values Using the Wako β-Glucan Test Assay in Patients with Probable or Proven Fungal Diseases

Elena De Carolis,Federica Marchionni,Riccardo Torelli,Patrizia Posteraro,Gennaro De Pascale,Simone Carelli,Maurizio Sanguinetti,Brunella Posteraro

Journal of Clinical Microbiology（2019）

Cited 3|Views54

No score

Abstract

Here, we report comparable results for the Wako β-glucan test (GT; FUJIFILM Wako Pure Chemical Corporation, Osaka, Japan), recently launched in Europe for testing the invasive fungal disease (IFD) biomarker 1,3-β-d-glucan (BDG) ([1][1][–][2][3][3]), in matched serum and plasma samples from

Translated text

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined